Solicitor general weighs in on Supreme Court review of drug price negotiations

Solicitor general weighs in on Supreme Court review of drug price negotiations

Solicitor General D. John Sauer is urging the Supreme Court to deny AstraZeneca’s petition to hear…

Continue Reading
Is GE HealthCare Still Attractive After Its Recent Share Price Climb and AI Momentum?

Is GE HealthCare Still Attractive After Its Recent Share Price Climb and AI Momentum?

Wondering if GE HealthCare Technologies is actually good value at today’s price, or if the recent…

Continue Reading
Medicare beneficiaries expected to save 5M from drug price negotiations

Medicare beneficiaries expected to save $685M from drug price negotiations

CMS announces billions in savings for Medicare when first and second rounds of negotiations go into…

Continue Reading
Is GE HealthCare Still Attractive After Its Recent Share Price Climb and AI Momentum?

Assessing Valuation Following Recent Share Price Movements

GE HealthCare Technologies (GEHC) has recently caught the attention of market watchers following a period of…

Continue Reading
Appeals court upholds Drug Price Negotiation Program

Appeals court upholds Drug Price Negotiation Program

The ruling dismisses a case brought by several chambers of commerce and their drug manufacturer members.…

Continue Reading
GE Healthcare soars 9% on earnings beat, wise guidance. Here’s our new price target

GE Healthcare soars 9% on earnings beat, wise guidance. Here’s our new price target

Things continue to look up for GE Healthcare stock this year. Shares of the medical technology…

Continue Reading